• OPEN AN ACCOUNT
Indian Indices
Sensex
78,581.00 0.00
( 0.00%)
Global Indices
Nasdaq
54,370.92 264.04
(0.49%)
Dow Jones
7,742.03 -15.49
(-0.20%)
Hang Seng
66,265.57 2,308.04
(3.61%)
Nikkei 225
10,894.52 15.14
(0.14%)
Forex
USD-INR
95.29 -0.10
(-0.11%)
EUR-INR
109.78 -0.22
(-0.20%)
GBP-INR
128.18 -0.43
(-0.33%)
JPY-INR
0.61 0.00
(0.31%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
163.1433353
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
48.88
2171.94
EPS(TTM)
Face Value()
Div & Yield %
26.87
10
0.02
 

V2 Retail consolidated net profit rises 171.89% in the March 2026 quarter
May 29,2026
Net profit of V2 Retail rose 171.89% to Rs 17.51 crore in the quarter ended March 2026 as against Rs 6.44 crore during the previous quarter ended March 2025. Sales rose 59.88% to Rs 797.02 crore in the quarter ended March 2026 as against Rs 498.51 crore during the previous quarter ended March 2025.

For the full year,net profit rose 124.99% to Rs 162.06 crore in the year ended March 2026 as against Rs 72.03 crore during the previous year ended March 2025. Sales rose 62.75% to Rs 3067.05 crore in the year ended March 2026 as against Rs 1884.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales797.02498.51 60 3067.051884.50 63
OPM %13.6911.60 -14.8513.68 -
PBDT89.1738.28 133 369.11196.87 87
PBT22.3810.35 116 186.9198.22 90
NP17.516.44 172 162.0672.03 125